A GLP-1 Drug That Activates Only Inside Cells May Work Better Than Ozempic
A Nature preclinical study describes an intracellular GLP-1 agonist that outperforms the standard GLP-1/GIP combination — in mice, not humans.
The news. The narrative. The timeline.
Bureau: Chicago
A Nature preclinical study describes an intracellular GLP-1 agonist that outperforms the standard GLP-1/GIP combination — in mice, not humans.
UNICEF documented its objection to Bangladesh's September 2025 procurement change with the phrase 'for God's sake'; the Rahman government reversed the change in April.
The US has 1,842 measles cases in 2026 — the highest since 1992 — and PAHO reviews US elimination status in November.
A Nature Communications trial from UC Cork shows coffee's microbiome effect is independent of caffeine — decaf improves memory, caffeinated coffee sharpens focus.
South Carolina's outbreak closed at 997 cases — the nation's largest in 35 years — and Utah's now-rising count is the obvious next chapter.